Manifold Partners’s AbbVie ABBV Stock Holding History

Manifold Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,640	Closed	-$216K	–	39
2015 Q4	$216K	Hold	3,640	–	–	0.19%	47
2015 Q3	$198K	Sell	3,640 -7,360	-67%	-$479K	0.18%	64
2015 Q2	$739K	Hold	11,000	–	–	0.66%	45
2015 Q1	$644K	Buy	+11,000	New	+$665K	0.64%	53
2013 Q4	–	Sell	-2,350	Closed	-$105K	–	101
2013 Q3	$105K	Sell	2,350 -950	-29%	-$42.1K	0.07%	70
2013 Q2	$136K	Buy	+3,300	New	+$144K	0.1%	64

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Manifold Partners's ABBV Position: Q1 2016 in Review

Manifold Partners sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 3,640 shares — an estimated $216K sold.

Manifold Partners first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $739K in Q2 2015. 1,640 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Manifold Partners reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Manifold Partners sold 3,640 AbbVie shares in Q1 2016, an estimated $216K.
Manifold Partners first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
Manifold Partners's AbbVie position peaked at $739K in Q2 2015.
1,640 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Manifold Partners's 13F filing for Q1 2016, filed 2 Jun 2016.